NOTRELOAD AI
  • NOTRELOAD AI
  • Invest ↗
  • myNOTRELOAD (BETA)
  • XY Feed
  • 24-HOUR Pass →
Sign in Subscribe

83% of Kids Tolerate More Peanut with VIASKIN Patch in Landmark Study

DBV Technologies reveals new VITESSE Phase 3 data at AAAAI 2026: 83% of kids on VIASKIN Peanut Patch increased safe peanut dose vs 48% on placebo, with excellent safety.

83% of Kids Tolerate More Peanut with VIASKIN Patch in Landmark Study
Photo by Vladislav Nikonov on Unsplash
Already have an account? Sign in.
03/02/2026 · 11:09 AM
DBVT
/ Don’t stop at just one post.

Related↓

Peanut Allergy Patch Shows 47% Success Rate in Children
12/16/2025 · 4:38 PM

Peanut Allergy Patch Shows 47% Success Rate in Children

DBV Technologies' (DBVT) VIASKIN Peanut patch shows significant success in treating peanut allergies in children aged 4-7, with nearly half of participants responding positively after one year.

/ Subscriber only
/ Read more

Feed↓

Bloom Energy Surges After Record Q1 2026 Beat: 130% Revenue Jump & Big Guidance Raise
04/28/2026 · 5:40 PM

Bloom Energy Surges After Record Q1 2026 Beat: 130% Revenue Jump & Big Guidance Raise

Bloom Energy beat earnings, doubled revenue, raised outlook, turned profit positive, and stock surged on strong AI/data center demand.

/ Subscriber only
Pernod Ricard Ends Merger Talks with Jack Daniel’s Owner
Featured/ 04/28/2026 · 5:27 PM

Pernod Ricard Ends Merger Talks with Jack Daniel’s Owner

Pernod Ricard ended merger talks with Brown-Forman over Jack Daniel’s as they couldn’t agree; shares fell and other deals may follow.

/ Subscriber only
Visa Crushes Q2 2026 with Strongest Revenue Growth Since 2022
Featured/ 04/28/2026 · 5:09 PM

Visa Crushes Q2 2026 with Strongest Revenue Growth Since 2022

Visa Q2 2026: revenue up 17%, profits beat expectations as card spending rose; strong travel spending, $20B buyback, stock up.

/ Subscriber only
  • UP↑
  • Terms/Privacy
  • Sign up
  • Sign in
  • Discord
  • X
  • Bluesky
  • Telegram
  • Reach out →
  • Invest ↗
  • NOTRELOAD AI
DON'T FALL BEHIND. ©2026
Email address Subscribe